Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer
Status:
Recruiting
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
A Prospective, Multicentre, Phase-IV Clinical Trial of Olaparib in Indian Patients with
Platinum Sensitive Relapsed Ovarian Cancer who are in Complete or Partial Response Following
Platinum based Chemotherapy and Metastatic Breast Cancer with germline BRCA (BReast CAncer
gene) 1/2 Mutation